drugset / Trial / NCT01255475
Blood Pressure Reduction in Heart Failure
Phase 2/3
Completed
21 enrolled
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Previous studies have demonstrated a direct association between blood pressure level and cardiovascular risk. However in patients with heart failure this association is considered controversial. The aim of this study is to evaluate the effect of the reduction of blood pressure in patients with heart failure. The investigators will examine the effects of this intervention over mortality, quality of life, and cardiac function.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-10
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Hydralazine | Small molecule | 100 mg | — |